Jim Connolly

Director/Board Member presso VALNEVA

59 anni

Health Technology

Commercial Services

Consumer Services

Profilo

James E.
Connolly currently works at Covenant House, Inc., as Director and Valneva SE, as Director from 2023.
Mr. Connolly also formerly worked at Aeras Global TB Vaccine Foundation, as President, Chief Executive Officer & Director from 2010 to 2013, Tivorsan Pharmaceuticals, Inc., as Chief Executive Officer & Director, International AIDS Vaccine Initiative, Inc., as Director from 2011 to 2013, Emergent Travel Health, Inc., as Director from 2014 to 2018, Pivotal Therapeutics, Inc., as Director in 2014, Vaxess Technologies, Inc., as Director, Ambulatus Robotics, Inc., as Director from 2020 to 2021, Wyeth Pharmaceuticals LLC, as Executive Vice President & General Manager, and Wyeth Canada ULC, as President.
Mr. Connolly received his undergraduate degree from Washington University in St. Louis.

Posizioni attive di Jim Connolly

Società	Posizione	Inizio
VALNEVA	Director/Board Member	24/06/2022
Covenant House, Inc.	Director/Board Member	-

Tutte le posizioni attive di Jim Connolly

Precedenti posizioni note di Jim Connolly

Società	Posizione	Fine
Ambulatus Robotics, Inc.	Director/Board Member	02/01/2021
Emergent Travel Health, Inc. Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.	Director/Board Member	01/10/2018
PIVOTAL THERAPEUTICS INC.	Director/Board Member	23/04/2014
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.	Director/Board Member	01/01/2013
Tivorsan Pharmaceuticals, Inc. Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI.	Chief Executive Officer	-

Vedi nel dettaglio l'esperienza di Jim Connolly

Formazione di Jim Connolly

Washington University in St. Louis

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jim Connolly

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
PIVOTAL THERAPEUTICS INC.	Finance
VALNEVA	Health Technology

Aziende private	9
Wyeth Pharmaceuticals LLC Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.	Health Technology
Aeras Global TB Vaccine Foundation Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.	Commercial Services
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.	Health Technology
Emergent Travel Health, Inc. Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.	Technology Services
Vaxess Technologies, Inc. Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA.	Commercial Services
Wyeth Canada ULC Wyeth Canada ULC Pharmaceuticals: MajorHealth Technology Wyeth Canada ULC manufactures and distributes pharmaceutical products. The company markets products in the areas of women's health care, neuroscience, musculoskeletal therapy, transplantation and immunology, hemophilia, and vaccines. It was founded in 1907 and is headquartered in Markham, Canada.	Health Technology
Covenant House, Inc.
Ambulatus Robotics, Inc.
Tivorsan Pharmaceuticals, Inc. Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI.	Health Technology